108 related articles for article (PubMed ID: 19010295)
21. Antioxidant therapy in multiple sclerosis.
Mirshafiey A; Mohsenzadegan M
Immunopharmacol Immunotoxicol; 2009; 31(1):13-29. PubMed ID: 18763202
[TBL] [Abstract][Full Text] [Related]
22. Tetrathiomolybdate in the treatment of acute hepatitis in an animal model for Wilson disease.
Klein D; Arora U; Lichtmannegger J; Finckh M; Heinzmann U; Summer KH
J Hepatol; 2004 Mar; 40(3):409-16. PubMed ID: 15123354
[TBL] [Abstract][Full Text] [Related]
23. Thalidomide derivatives for the treatment of neuroinflammation.
Contino-Pépin C; Parat A; Patinote C; Roscoe WA; Karlik SJ; Pucci B
ChemMedChem; 2010 Dec; 5(12):2057-64. PubMed ID: 20936622
[TBL] [Abstract][Full Text] [Related]
24. Tracing copper-thiomolybdate complexes in a prospective treatment for Wilson's disease.
Zhang L; Lichtmannegger J; Summer KH; Webb S; Pickering IJ; George GN
Biochemistry; 2009 Feb; 48(5):891-7. PubMed ID: 19146437
[TBL] [Abstract][Full Text] [Related]
25. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
Roscoe WA; Welsh ME; Carter DE; Karlik SJ
J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483
[TBL] [Abstract][Full Text] [Related]
26. Effects of tetrathiomolybdate and penicillamine on brain hydroxyl radical and free copper levels: a microdialysis study in vivo.
Zhang JW; Liu JX; Hou HM; Chen DB; Feng L; Wu C; Wei LT; Li XH
Biochem Biophys Res Commun; 2015 Feb; 458(1):82-5. PubMed ID: 25634697
[TBL] [Abstract][Full Text] [Related]
27. The promise of copper lowering therapy with tetrathiomolybdate in the cure of cancer and in the treatment of inflammatory disease.
Brewer GJ
J Trace Elem Med Biol; 2014 Oct; 28(4):372-8. PubMed ID: 25194954
[TBL] [Abstract][Full Text] [Related]
28. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE).
Olechowski CJ; Truong JJ; Kerr BJ
Pain; 2009 Jan; 141(1-2):156-64. PubMed ID: 19084337
[TBL] [Abstract][Full Text] [Related]
29. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.
Vogt J; Paul F; Aktas O; Müller-Wielsch K; Dörr J; Dörr S; Bharathi BS; Glumm R; Schmitz C; Steinbusch H; Raine CS; Tsokos M; Nitsch R; Zipp F
Ann Neurol; 2009 Sep; 66(3):310-22. PubMed ID: 19798635
[TBL] [Abstract][Full Text] [Related]
30. Vitamin D as an immune modulator in multiple sclerosis, a review.
Smolders J; Damoiseaux J; Menheere P; Hupperts R
J Neuroimmunol; 2008 Feb; 194(1-2):7-17. PubMed ID: 18177949
[TBL] [Abstract][Full Text] [Related]
31. [Uric acid as a scavenger in oxidative stress].
Staub M
Orv Hetil; 1999 Feb; 140(6):275-9. PubMed ID: 10071505
[TBL] [Abstract][Full Text] [Related]
32. An antibody to IP-10 is a potent antagonist of cell migration in vitro and in vivo and does not affect disease in several animal models of inflammation.
Byrne FR; Winters A; Brankow D; Hu S; Juan T; Steavenson S; Doellgast G; Kuchimanchi K; Brown H; Anderson S; Smelt S; Sullivan T; Alcorn D; Tocker J; Dean C; Macmaster J; Kirchner J; Buys J; Manoukian R; Jiao E; Zou X; Campanella GS; Siu G
Autoimmunity; 2009 Mar; 42(3):171-82. PubMed ID: 19301198
[TBL] [Abstract][Full Text] [Related]
33. Tetrathiomolybdate anticopper therapy for Wilson's disease inhibits angiogenesis, fibrosis and inflammation.
Brewer GJ
J Cell Mol Med; 2003; 7(1):11-20. PubMed ID: 12767257
[TBL] [Abstract][Full Text] [Related]
34. Acute neuroinflammation in Lewis rats - a model for acute multiple sclerosis relapses.
Schneider C; Schuetz G; Zollner TM
J Neuroimmunol; 2009 Aug; 213(1-2):84-90. PubMed ID: 19560215
[TBL] [Abstract][Full Text] [Related]
35. Beneficial actions of oleanolic acid in an experimental model of multiple sclerosis: a potential therapeutic role.
Martín R; Carvalho-Tavares J; Hernández M; Arnés M; Ruiz-Gutiérrez V; Nieto ML
Biochem Pharmacol; 2010 Jan; 79(2):198-208. PubMed ID: 19679109
[TBL] [Abstract][Full Text] [Related]
36. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells.
Ellestad KK; Tsutsui S; Noorbakhsh F; Warren KG; Yong VW; Pittman QJ; Power C
J Immunol; 2009 Jul; 183(1):298-309. PubMed ID: 19542441
[TBL] [Abstract][Full Text] [Related]
37. The calcitonin/calcitonin gene related peptide-alpha gene is not required for 1alpha,25-dihydroxyvitamin D3-mediated suppression of experimental autoimmune encephalomyelitis.
Becklund BR; James BJ; Gagel RF; DeLuca HF
Arch Biochem Biophys; 2009 Aug; 488(2):105-8. PubMed ID: 19563774
[TBL] [Abstract][Full Text] [Related]
38. Glucocorticoids in the control of neuroinflammation.
Tischner D; Reichardt HM
Mol Cell Endocrinol; 2007 Sep; 275(1-2):62-70. PubMed ID: 17555867
[TBL] [Abstract][Full Text] [Related]
39. Lessons from multiple sclerosis: models, concepts, observations.
Wekerle H
Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii56-60. PubMed ID: 19022815
[TBL] [Abstract][Full Text] [Related]
40. Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis model.
Jung EJ; Hur M; Kim YL; Lee GH; Kim J; Kim I; Lee M; Han HK; Kim MS; Hwang S; Kim S; Woo AM; Yoon Y; Park HJ; Won J
J Pharmacol Exp Ther; 2009 Dec; 331(3):1005-13. PubMed ID: 19741152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
